Omnigen AE is one of the most modern stem cell banks and integrated biotechnology company in Europe. The purpose of Omnigen AE is to operate in the field of stem cells, cell therapies, and regenerative medicine, and to follow the most modern and safe methods using state-of-the-art equipment. The company’s labs offer molecular tests for cystic fibrosis, thrombophilia, Pap tests, male infertility, and HPV. Omnigen AE is one of the first companies to receive an opinion from the National Transplant Organization and operates as a bank of primary umbilical cord blood cells and as a bank of human umbilical cord tissue and cells.
Lastly, as Nicolaos Notaras, CEO of Omnigen Stem Cell Bank told us, “more and more personalized experimental applications, as well as new data in immunology, have made umbilical cord blood care a responsibility. For example, in the US alone, over 1,500,000 couples have stored this valuable biological material for their families, while in the United Kingdom more than 30,000 couples per year. Statistics show us that family care is increasing
its rates against donation steadily in recent years. Strict European legislation and guidelines specific to organ transplants ensure the quality characteristics of these transplants and make them completely controlled and safe for the whole family.